- Home
- HXHX vs CLRB Comparison
HXHX vs CLRB Comparison
Compare HXHX & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- CLRB
- Stock Information
- Founded
- HXHX 2003
- CLRB 2002
- Country
- HXHX China
- CLRB United States
- Employees
- HXHX N/A
- CLRB N/A
- Industry
- HXHX Trucking Freight/Courier Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- CLRB Health Care
- Exchange
- HXHX Nasdaq
- CLRB Nasdaq
- Market Cap
- HXHX 13.3M
- CLRB 14.2M
- IPO Year
- HXHX 2025
- CLRB N/A
- Fundamental
- Price
- HXHX $1.19
- CLRB $5.15
- Analyst Decision
- HXHX
- CLRB Hold
- Analyst Count
- HXHX 0
- CLRB 2
- Target Price
- HXHX N/A
- CLRB N/A
- AVG Volume (30 Days)
- HXHX 234.7K
- CLRB 129.4K
- Earning Date
- HXHX 01-01-0001
- CLRB 08-14-2025
- Dividend Yield
- HXHX N/A
- CLRB N/A
- EPS Growth
- HXHX N/A
- CLRB N/A
- EPS
- HXHX 0.26
- CLRB N/A
- Revenue
- HXHX $25,571,810.00
- CLRB N/A
- Revenue This Year
- HXHX N/A
- CLRB N/A
- Revenue Next Year
- HXHX N/A
- CLRB N/A
- P/E Ratio
- HXHX $5.14
- CLRB N/A
- Revenue Growth
- HXHX N/A
- CLRB N/A
- 52 Week Low
- HXHX $0.84
- CLRB $4.11
- 52 Week High
- HXHX $6.29
- CLRB $67.50
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- CLRB 53.59
- Support Level
- HXHX N/A
- CLRB $4.82
- Resistance Level
- HXHX N/A
- CLRB $5.34
- Average True Range (ATR)
- HXHX 0.00
- CLRB 0.36
- MACD
- HXHX 0.00
- CLRB 0.08
- Stochastic Oscillator
- HXHX 0.00
- CLRB 79.12
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.